ISPE Names AstraZeneca China Facility of the Year Winner

Nov 11, 2015

International Society for Pharmaceutical Engineering (ISPE) announced AstraZeneca China as the 2015 Facility of the Year Awards (FOYA) Overall Winner. The winner was revealed at ISPE’s Annual Meeting in Philadelphia, PA.

AstraZeneca China’s Market Supply Solid Dose Facility located in Taizhou, China, was built to manufacture five billion tablets of medicines per year to the China market. The 533,000-square-foot facility was completed in a record time of 20 months, coming in 18 percent under budget and maintaining an exemplary safety record of 3.26M hours worked without a recordable incident, according to ISPE.

“The Taizhou Supply Site Project is the perfect representation of the FOYA program,” said ISPE president and CEO John Bournas. “AstraZeneca China’s mission to deliver high-quality pharmaceuticals to China’s growing population was carried out seamlessly through first-rate global engineering and operational organization. It demonstrates visionary pharmaceutical excellence undertaken in an emerging market.”

AstraZeneca’s project team incorporated lean design principles to eliminate operational inefficiencies and deliver optimum manufacturing performance, ISPE said. The facility exceeded local environmental regulations and AstraZeneca’s own stringent standards with a 99 percent Active Pharmaceutical Ingredient (API) removal rate from API containing waste water.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments